OICS v0.3.3 class · Healthcare

Generics & Consumer Health

ID GNX HC.PH.PHA.GNX

Makes generic or biosimilar medicines, off-patent or reformulated specialty drugs, over-the-counter and consumer-health products (including vitamins, dietary supplements and medical nutrition), active ingredients, or compounded drugs, for humans or animals; a drugmaker goes by what earns most, its own patented medicines or the rest.

Where it sits

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector: HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group: HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry: HC.PH.PHA Pharmaceuticals in the standard Selling approved medicines at scale.

Companies in this class

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

All companies1,258 Listed with filings866

Largest first Name Country

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company	Ticker	Country	Market cap	Filings
Mekophar Chemical Pharmaceutical JSC	MKP	Viet Nam	—	402
CTCP Armephaco	AMP	Viet Nam	—	398
CTCP Dược phẩm TW25	UPH	Viet Nam	—	398
Central Pharmaceutical JSC No3	DP3	Viet Nam	—	397
PT Ikapharmindo Putramas Tbk.	IKPM	Indonesia	—	395
NUTRITIONAL GROWTH SOLUTIONS LTD	NGS	Australia	—	388
TAIKO PHARMACEUTICAL CO., LTD.	4574	Japan	—	387
峆一药业	920478	China	—	379
Công ty Cổ phần Dược Hậu Giang	DHG	Viet Nam	—	378
Zhongzhi Pharmaceutical Holdings Limited	3737	Hong Kong	—	377
Vitality Products Inc.	VPI	Canada	—	376
Ferozsons Laboratories Limited	FEROZ	Pakistan	—	371
KOREA ARLICO PHARM CO.,LTD.	260660	South Korea	—	371
SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD.	688163	China	—	370
Golden Throat Holdings Group Company Limited	6896	Hong Kong	—	367
JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.	603235	China	—	366
Hangzhou Minsheng Healthcare Co., Ltd.	301507	China	—	365
Blis Technologies Limited	BLT	New Zealand	—	361
Sanofi Consumer Healthcare India Limited	SANOFICONR	India	—	361
Fuso Pharmaceutical Industries,Ltd.	4538	Japan	—	357
Promino Nutritional Sciences Inc.	MUSL	Canada	—	356
无锡晶海	920547	China	—	355
Solarvest BioEnergy Inc.	SVS	Canada	—	352
Jolt Health Inc.	JOLT	Canada	—	351
National Day Pharmaceutical JSC of HCM City	NDP	Viet Nam	—	351
Beijing Tong Ren Tang Chinese Medicine Company Limited	3613	Hong Kong	—	350
CTCP Nam Dược	NDC	Viet Nam	—	347
Optimi Health Corp.	OPTI	Canada	—	343
Ganga Pharmaceuticals Limited	539680	India	—	338
DongKoo Bio & Pharma Co., Ltd.	006620	South Korea	—	332
Dongnai Pharmaceutical JSC	DPP	Viet Nam	—	330
ANLON HEALTHCARE LIMITED	AHCL	India	—	328
Công ty cổ phần Dược Trung Ương Mediplantex	MED	Viet Nam	—	328
BIOME AUSTRALIA LIMITED	BIO	Australia	—	321
H.PIO Co., Ltd.	357230	South Korea	—	321
Fuji Pharma Co.,Ltd.	4554	Japan	—	319
Genix Pharmaceuticals Corporation	GENX	Canada	—	316
Kwangdong Healthbio Co., Ltd.	086220	South Korea	—	316
SAWAI GROUP HOLDINGS Co., Ltd.	4887	Japan	—	316
海昇药业	920656	China	—	316
AGP Limited	AGP	Pakistan	—	315
Eevia Health Plc	EEVIA	Finland	—	315
Achyut Healthcare Limited	543499	India	—	314
Otsuka Pakistan Limited	OTSU	Pakistan	—	313
Central Pharmaceutical CPC1 JSC	DP1	Viet Nam	—	311
Haleon Pakistan Limited	HALEON	Pakistan	—	306
NIPPON CHEMIPHAR CO., LTD.	4539	Japan	—	306
NanoSphere Health Sciences Inc.	NSHS	Canada	—	305
SINSIN PHARMACEUTICAL Co., LTD.	002800	South Korea	—	304
HLSCIENCE Co., LTD	239610	South Korea	—	298

Companies in Pharmaceuticals → Open in the screener →

Boundaries

Other names for this activity, and where neighboring activities go instead.

Also known as

genericsOTCAPI manufacturerbiosimilars

Not here

makes ingredients or drugs under contract for other drug companies → CRO Contract Research & Manufacturing
mostly its own patented medicines → RXB Branded Prescription Drugs or CMB Commercial Biotech

Sent here from

Other classes in Pharmaceuticals

Branded Prescription Drugs RXB HC.PH.PHA.RXB

Discovers, develops and markets branded prescription medicines or vaccines with approved products in at least three therapeutic areas, for humans or animals; a company moves between this class and Commercial Biotech only after two consecutive annual reports on the other side.

Also big pharma, innovative pharmaceuticals, animal health

Not here no approved product → CLB Clinical-Stage Biotech
Not here approved products in one or two therapeutic areas, research-led → CMB Commercial Biotech
Not here mostly generics, off-patent brands and over-the-counter products → GNX Generics & Consumer Health

Permanent link

https://financialfilings.com/oics/GNX/

This page is keyed by the class ID GNX. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard